Last A$1.75 AUD
Change Today +0.045 / 2.65%
Volume 1.0K
VSC On Other Exchanges
Symbol
Exchange
Frankfurt
As of 10:03 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

vita life sciences ltd (VSC) Snapshot

Open
A$1.75
Previous Close
A$1.70
Day High
A$1.75
Day Low
A$1.75
52 Week High
09/9/13 - A$1.89
52 Week Low
04/23/13 - A$0.99
Market Cap
99.3M
Average Volume 10 Days
20.6K
EPS TTM
A$0.06
Shares Outstanding
56.9M
EX-Date
03/17/14
P/E TM
27.2x
Dividend
A$0.03
Dividend Yield
1.82%
Current Stock Chart for VITA LIFE SCIENCES LTD (VSC)

Related News

No related news articles were found.

vita life sciences ltd (VSC) Related Businessweek News

No Related Businessweek News Found

vita life sciences ltd (VSC) Details

Vita Life Sciences Limited engages in formulating, packaging, selling, and distributing vitamins and supplements. The company operates in two segments, Health and Investment. It offers a range of supplements, vitamins, minerals, meal replacement, sports nutrition, and herbals for men, women, and children; and over the counter products. The company markets its products through pharmacies and health food stores primarily under the VitaHealth and Herbs of Gold brand names. It operates in Australia, Malaysia, Singapore, and other countries. Vita Life Sciences Limited was founded in 1947 and is headquartered in Melbourne, Australia.

Founded in 1947

vita life sciences ltd (VSC) Top Compensated Officers

Chairman of The Board and Managing Director
Total Annual Compensation: A$130.6K
Senior General Manager of Asian Business and ...
Total Annual Compensation: A$243.3K
General Manager of Thailand
Total Annual Compensation: A$85.8K
Compensation as of Fiscal Year 2013.

vita life sciences ltd (VSC) Key Developments

Vita Life Sciences Limited Announces Final Dividend for the 2013, Payable on 28 March 2014

Vita Life Sciences Limited announced unfranked final dividend for the 2013 financial year have been updated, noting specifically the amendment to the ex-dividend date. The amount per security of 2.0 cents will be payable on 28 March 2014 to the holders of record on 21 March 2014 with ex-dividend date of 17 March 2014.

Vita Life Sciences Limited Reports Earnings Results for the Year Ended December 31, 2013; Provides Earnings Guidance for the Full Year 2014

Vita Life Sciences Limited reported earnings results for the year ended December 31, 2013. For the period, the company reported revenue of AUD 35.41 million against AUD 30.19 million a year ago. EBITDA was AUD 5.62 million against AUD 2.93 million a year ago. EBIT was AUD 5.51 million against AUD 2.86 million a year ago. Profit before tax was AUD 5.52 million against AUD 2.84 million a year ago. Profit after tax was AUD 4.75 million or 8.42 cents diluted per share against profit after tax of AUD 2.32 million or 4.14 cents diluted per share a year ago. Operating cash flows was AUD 4.83 million against AUD 1.39 million a year ago. For 2014, the company expects full year sales growth of approximately 13 - 15% against that reported to Dec. 2013; and an EBIT margin of approximately 14% to 16%.

Vita Life Sciences Limited Announces Board Changes

At a meeting of Directors on October 22, 2013, Mr. Vanda Gould stepped down as Chairman of the Board of Vita Life Sciences Limited effective immediately. Mr. Gould will continue his involvement with the company as a non-executive Director. The company's Managing Director Mr. Eddie Tie was appointed Acting Chairman.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VSC:AU A$1.75 AUD +0.045

VSC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for VSC.
View Industry Companies
 

Industry Analysis

VSC

Industry Average

Valuation VSC Industry Range
Price/Earnings 21.7x
Price/Sales 2.9x
Price/Book 6.3x
Price/Cash Flow 21.9x
TEV/Sales 2.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VITA LIFE SCIENCES LTD, please visit www.vitalifesciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.